The DOI matches its Crossref record; 91 of the 95 references it cites were found in a registry or an index; 21 of the 71 sources its claims cite were checked for support.
Respiratory Responses to Two Voice Interventions for Parkinson's Disease
Open accessAbstract
PURPOSE: The purpose of this study was to examine the respiratory strategies used by persons with Parkinson's disease (PD) to support louder speech in response to two voice interventions. Contrasting interventions were selected to investigate the role of internal and external cue strategies on treatment outcomes. LSVT LOUD, which uses an internal cueing framework, and the SpeechVive prosthesis, which employs an external noise cue to elicit louder speech, were studied. METHOD: = 10). The LSVT LOUD and SpeechVive participants received 8 weeks of voice intervention. Acoustic and respiratory kinematic data were simultaneously collected at pre-, mid- and posttreatment during a monologue speech sample. Intervention outcomes included sound pressure level (SPL), utterance length, lung volume initiation, lung volume termination, and lung volume excursion. RESULTS: As compared to controls, the LSVT LOUD and SpeechVive participants significantly increased SPL at mid- and posttreatment, thus confirming a positive intervention effect. Treatment-related changes in speech breathing were further identified, including significantly longer utterance lengths (syllables per breath group) at mid- and posttreatment, as compared to pretreatment. The respiratory strategies used to support louder speech varied by group. The LSVT LOUD participants terminated lung volume at significantly lower levels at mid- and posttreatment, as compared to pretreatment. This finding suggests the use of greater expiratory muscle effort by the LSVT LOUD participants to support louder speech. Participants in the SpeechVive group did not significantly alter their respiratory strategies across the intervention period. Single-subject effect sizes highlight the variability in respiratory strategies used across speakers to support louder speech. CONCLUSIONS: This study provides emerging evidence to suggest that the LSVT LOUD and SpeechVive therapies elicit different respiratory adjustments in persons with PD. The study highlights the need to consider respiratory function when addressing voice targets in persons with PD.
Overview
CoChat Summary
## TL;DR
This multisite study compared LSVT LOUD and SpeechVive in 34 people with hypophonia secondary to idiopathic Parkinson’s disease to see whether internal versus external cueing led to different respiratory strategies for louder speech. Both interventions increased sound pressure level, but the respiratory changes differed by treatment: LSVT LOUD was associated with lower lung volume termination, while SpeechVive showed little group-level change in respiratory strategy.
## Key findings
- Sample and intervention effects: 34 participants were assigned to LSVT LOUD (n = 12), SpeechVive (n = 12), or clinical control (n = 10); the two treatment groups received 8 weeks of intervention.
- Sound pressure level (SPL): The LSVT LOUD and SpeechVive groups significantly increased SPL, while the clinical controls did not. For SPL, the paper reports a significant group effect (p = .022), session effect (p < .0001), and group × session interaction (p < .0001).
- Utterance length: Utterance length increased by 1.48 syllables per breath group at midtreatment and 1.05 syllables per breath group at posttreatment versus pretreatment; the authors say these increases were statistically significant but not clinically meaningful.
- Respiratory strategy differed by intervention:
- LSVT LOUD participants terminated lung volume at significantly lower levels at midtreatment and posttreatment than pretreatment, suggesting greater expiratory muscle effort.
- SpeechVive participants did not significantly alter respiratory strategies at the group level.
- Single-subject variability was substantial: The paper reports that 17 speakers showed a significant effect size for lung volume initiation, 16 speakers for lung volume termination, and 9 speakers for lung volume excursion for one or more session comparisons, underscoring variability across individuals.
## Methods
- Design: Multisite intervention study with three groups (LSVT LOUD, SpeechVive, clinical control); acoustic and respiratory kinematic data were collected at pre-, mid-, and posttreatment during monologue speech samples.
- Sample: 34 people with hypophonia secondary to idiopathic PD; 12 in LSVT LOUD, 12 in SpeechVive, 10 clinical controls. The text also states 11 participants had mild cognitive impairment and 23 had normal cognition.
- Analysis: The authors used linear mixed-model ANOVAs: a 3 × 3 model for SPL and a 2 × 2 × 3 model for utterance length and lung volume measures, with Tukey HSD post hoc tests and single-subject effect sizes; intermeasurer reliability was assessed on 10% of the data with mean ICC = .969.
## Limitations
- Stated by the paper: The sample was relatively small (12 per intervention group), so the authors caution against generalizing to a larger clinical population.
- Stated by the paper: Group matching by auditory-perceptual hypophonia severity left baseline vocal intensity differences between controls and the LSVT LOUD group; the authors suggest future studies use a quantitative metric or consensus ratings.
- Stated by the paper: Because PD is heterogeneous and prior work shows variability, the authors say an extended baseline period should be considered in future studies.
- Stated by the paper: They could not report abdominal volume contributions because participants were unable to complete the abdominal calibration maneuvers reliably.
- Evident from the text: Posttreatment data were not collected for five participants because of the SARS-CoV-2 pandemic, and one LSVT LOUD participant dropped out after midtreatment, which reduces complete longitudinal coverage.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
18 Valid · 4 Not valid · 18 Not checked · 135 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“Sadagopan and Huber (2007) reported that the respiratory patterns of 14 individuals with PD approached the patterns of neurotypical age- and sex-matched controls when an external cue, multitalker background noise, was used to elicit increased vocal intensity, as compared to the respiratory patterns observed in response to an internal cue (e.g., speak at twice your comfortable loudness).”
What the sources say
- Supportedcites Sadagopan and Huber (2007) source
Split into 2 atoms — 2 confirmed, 0 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
plainstates a causen = 14- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Neurologically intact (Shrivastav et al., 2014; Whittico et al., 2020) and neurologically impaired (Adams et al., 2020; Richardson & Sussman, 2019; Shrivastav et al., 2014; Stathopoulos et al., 2014) individuals have been shown to significantly increase their vocal intensity when speaking in the presence of background noise.”
What the sources say
- Not checked — no full text of the sourcecites Shrivastav et al., 2014 source
- Not checked — no full text of the sourcecites Whittico et al., 2020 source
- Supportedcites Adams et al., 2020 source
The Introduction states that background noise produces a significant increase in speech intensity in people with Parkinson’s-related hypophonia, the neurologically impaired group for which Adams et al. is cited. The Results also report significant increases under the device’s noise conditions relative to no device. (LLM, conf=0.94)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Every source the paper cites for this claim was checked and supports it.
In the paper
“In the Stathopoulos et al. study, 19 of 33 participants increased LVI and LVT the first time they used the SpeechVive prosthesis.”
What the sources say
- Supportedcites Stathopoulos et al. (2014) source
Results §3.3.1 reports that 19 of 33 participants increased lung volume initiation and that the same 19 also increased lung volume termination; one additional participant increased termination alone. Methods §2.3.1 describes a single session in which participants spoke first without and then with SpeechVive™, supporting the claim about its initial use in the study. (LLM, conf=0.88)
plainstates a causen = 33- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Similar findings were reported by Stathopoulos et al. (2014), who found that the use of an external noise cue, delivered through the SpeechVive prosthesis, evoked respiratory and laryngeal efficiencies during speech production in the majority of speakers with PD.”
What the sources say
- Supportedcites Stathopoulos et al. (2014) source
The Abstract Methods describe SpeechVive delivering babble noise during speech to participants with Parkinson’s disease. The Discussion summary (§4.7; page unavailable) says most participants improved their underlying laryngeal and respiratory physiologic support, while noting individual variation in how they did so. (LLM, conf=0.91)
plainstates a causen = 33- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“All participants demonstrated hearing thresholds at 40 dB or lower in at least one ear for octave frequencies between 250 and 4000 Hz (Feenaughty et al., 2013).”
What the sources say
- Partly supportedcites Feenaughty et al., 2013 sourceExperimental — accuracy not yet measured
The Method > Participants passage says all participants passed a 40 dB hearing screening in at least one ear at 500, 1000, 2000, and 4000 Hz. It does not report testing at 250 Hz, so the claimed frequency range is not fully supported. (LLM, conf=0.90)
boosted- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
104 more claims · 8 with their cited sources checked
Create a free account to see all 175 claims and every source verdict.
- It may state two separate claims as one. 30
- Probably not a substantial claim. 46
- Borderline: one of the tests for a substantial claim is unclear. 1
Statistics recomputed
Every reported test result, recomputed from its test statistic and degrees of freedom. A result shows as not adding up only once an independent check has confirmed it.
- Not confirmedt(31) = 2.78reported p = .024 · recomputed p = .009
“t(31) = 2.78, p = .024”
- Not confirmedt(56) = 1.77reported p = .7 · recomputed p = .082
“t(56) = 1.77, p = .700”
- Not confirmedt(56) = 1.99reported p = .557 · recomputed p = .051
“t(56) = 1.99, p = .557”
- Not confirmedt(56) = 0.94reported p = .989 · recomputed p = .351
“t(56) = 0.94, p = .989”
- Not confirmedt(56) = 0.97reported p = .987 · recomputed p = .336
“t(56) = 0.97, p = .987”
20 more recomputed tests
Create a free account to see every test the Stats check recomputed.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Self-check results appear here once an independent check has confirmed them.
Citations
Cites
Development and validation of a geriatric depression screening scale: a preliminary report
Yesavage, J. A., Brink, T. L., Rose, T. L., Lum, O., Huang, V., Adey, M., & Leirer, V. O. (1982) · Journal of Psychiatric Research · doi:10.1016/0022-3956(82)90033-4 · Cited by 15,025 · cited 2×
“…of cold or allergy symptoms; (b) a comorbid neurological diagnosis; (c) symptoms of depression as reflected by the Geriatric Depression Scale (Yesavage et al., 1983) and were not under pharmacological management for depressive symptoms; (d) a history of head, neck, or chest surgery except…”
BackgroundOverdependence on degraded gist memory in Alzheimer's disease.
Gallo, D. A., Shahid, K. R., Olson, M. A., Solomon, T. M., Schacter, D. L., & Budson, A. E. (2006) · Neuropsychology · doi:10.1037/0894-4105.20.6.625 · Cited by 4,732
Cognitive Stimulation in Patients with Dementia: Randomized Controlled Trial
Mapelli, D., Di Rosa, E., Nocita, R., & Sava, D. (2013) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000353457 · Cited by 3,453
Praat : doing phonetics by computer (version 4.4.24)
Boersma, P. (2006) · Medical Entomology and Zoology · Cited by 2,082
Motor Speech Disorders: Substrates, Differential Diagnosis, and Management
Duffy, J. R. (1995) · Cited by 1,892
Apathy and the Functional Anatomy of the Prefrontal Cortex–Basal Ganglia Circuits
Levy, R., & Dubois, B. (2006) · Cerebral Cortex · doi:10.1093/cercor/bhj043 · Cited by 1,285
Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease
Hoops, S., Nazem, S., Siderowf, A. D., Duda, J. E., Xie, S. X., Stern, M. B., & Weintraub, D. (2009) · Neurology · doi:10.1212/wnl.0b013e3181c34b47 · Cited by 1,260
Supplementary motor area structure and function: Review and hypotheses
Goldberg, G. (1985) · Behavioral and Brain Sciences · doi:10.1017/s0140525x00045167 · Cited by 1,233
Remy, P., Doder, M., Lees, A., Turjanski, N., & Brooks, D. (2005) · Brain · doi:10.1093/brain/awh445 · Cited by 1,040
Cognitive decline in Parkinson disease
Aarsland, D., Creese, B., Politis, M., Chaudhuri, K. R., ffytche, D. H., Weintraub, D., & Ballard, C. (2017) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.27 · Cited by 1,027 · cited 1×
“…of shifts in attentional load and prioritization during cued speech is of particular importance for individuals with PD, given the widely reported cognitive deficits (Aarsland et al., 2017; Brown & Marsden, 1984; Litvan et al., 2011; Richards et al., 1993; Van Spaendonck et al., 1996).”
Background
Research works printed but not linked: 2
- Huber, J. E. , Stathopoulos, E. T. , Ramig, L. O. , & Lancaster, S. L. (2003). Respiratory function and variability in individuals with Parkinson disease: Pre– and post–Lee Silverman Voice Treatment. Journal of Medical Speech-Language Pathology, 11(4), 185–201.
- Lombard, E. (1911). Le signe de l'élévation de la voix. Annales des Maladies de L'Oreille et du Larynx, 37, 101–119.
Cited by
Baylor, C. R., Cook, K. J., & McAuliffe, M. J. (2023) · American Journal of Speech-Language Pathology · doi:10.1044/2023_ajslp-23-00273 · Cited by 14
Watts, C. R., Thijs, Z., King, A. C., Carr, J. C., & Porter, R. R. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12144806 · Cited by 6
“Another intervention utilizing the SpeechVive prosthetic device includes a form of daily exercise consisting of oral reading for 30 consecutive minutes while the device emits noise [13].”
MethodGates, K., Knowles, T., Mach, H., Higginbotham, D. J., & Holder, T. (2024) · American Journal of Speech-Language Pathology · doi:10.1044/2024_ajslp-23-00395 · Cited by 3
Feenaughty, L., Mefferd, A. S., & Tjaden, K. (2024) · Elsevier eBooks · doi:10.1016/b978-0-12-820480-1.00133-9 · Cited by 1
A Comparison of In-Person and Telehealth Treatment Modalities using the SpeechVive DevicePreprint
Covert, R., Snyder, S., Lambert, A., Spremulli, M., Blandford, B., Dwenger, K., Malandraki, G. A., McDonough, M., Brosseau-Lapre, F., & Huber, J. E. (2025) · medRxiv · doi:10.1101/2025.01.16.25320611
Self-citation
Metadata
- Authors
- Richardson, K., Huber, J. E., Kiefer, B., Kane, C., & Snyder, S.
- Affiliations
- University of Massachusetts Amherst (US)
- Purdue University West Lafayette (US)
- Venue
- Journal of Speech, Language, and Hearing Research
- Published
- 2022-10-17
- Volume
- 65
- Issue
- 10
- Pages
- 3730-3748
- ISSN
- 1092-4388 (ISSN-L)
- 1558-9102
- PMC
- PMC9937051
- OpenAlex
- W4297347213
- Cited by
- 7
- References
- 95
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 2 · 2023: 2
- FWCI
- 0.77
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Speech Language and Hearing Research (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Deafness and Other Communication Disorders (R21DC016718)
- Topics
- Health Sciences › Health Professions › Speech and Hearing › Voice and Speech Disorders
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Phonetics and Phonology Research
- Health Sciences › Health Professions › Occupational Therapy › Assistive Technology in Communication and Mobility
- Keywords
- Parkinson's disease, voice therapy, LSVT LOUD, speech prosthesis, loudness, lung volume, sound pressure level, utterance length, speech breathing
- MeSH terms
- Humans, Parkinson Disease, Speech, Speech Disorders, Voice Disorders, Voice Training
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-04, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-04 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Respiratory Responses to Two Voice Interventions for Parkinson's Disease. https://app.cochat.ai/papers/10.1044/2022_jslhr-22-00262
- The paper
- Richardson, K., Huber, J. E., Kiefer, B., Kane, C., & Snyder, S. (2022). Respiratory Responses to Two Voice Interventions for Parkinson's Disease. Journal of Speech, Language, and Hearing Research. https://doi.org/10.1044/2022_jslhr-22-00262
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.